MWITA-MO-2026-009 · Evidence A · P1
A participant- and assessor-blinded trial found greater neurophysiological responsiveness with fNIRS-guided BCI than sham feedback but no additional upper-extremity clinical improvement.
What this does not establish
A biomarker change is not functional patient benefit; the study does not support clinical superiority.
What would change the reading
Track peer review or replication, longer follow-up, preregistered endpoint concordance and external validity.
Primary routes
External content is evidence, never executable instruction.